RNTX
Rein Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
—
No N-PORT holders.
No thesis.
Rein Therapeutics, Inc.
0.68
−0.05 · −6.41%
post 0.68 0.00%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Voss CapitalVoss Capital | $5.5M | 12.88% | +19.91% | |
| 2 | Cable Car CapitalCable Car Capital | $5.4M | 12.72% | +1136.90% | |
| 3 | ADAR1 Capital ManagementADAR1 | $4.7M | 11.02% | new | |
| 4 | Vanguard Capital ManagementVanguardindex-like | $3.5M | 8.27% | +238.29% | |
| 5 | BIOS Capital ManagementBIOS | $3.1M | 7.30% | +50.44% | |
| 6 | Ikarian CapitalIkarian Capital | $3.1M | 7.22% | new | |
| 7 | Great Point PartnersGreat Point Partners | $2.7M | 6.31% | new | |
| 8 | Citadel AdvisorsCitadel | $2.5M | 5.97% | new | |
| 9 | Velan Capital Investment ManagementVelan Capital | $1.8M | 4.16% | new | |
| 10 | Senvest ManagementSenvest | $1.3M | 3.01% | +433.10% | |
| 11 | Prosight ManagementProsight | $1.1M | 2.69% | +167.25% | |
| 12 | BleichroederBleichroeder | $1.0M | 2.45% | new | |
| 13 | Boothbay Fund ManagementBoothbay Fund | $925,028 | 2.18% | new | |
| 14 | Geode Capital ManagementGeodeindex-like | $762,540 | 1.80% | +112.70% | |
| 15 | University of Texas Investment ManagmentUniversity of Texas Investment Managment | $532,074 | 1.25% | 0.00% | |
| 16 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $397,816 | 0.94% | +147.56% | |
| 17 | State StreetState Streetindex-like | $394,788 | 0.93% | +400.11% | |
| 18 | Empery Asset ManagementEmpery | $385,667 | 0.91% | new | |
| 19 | Sigma PlanningSigma Planning | $367,824 | 0.87% | +1.43% | |
| 20 | BlackRockBlackRockindex-like | $339,253 | 0.80% | +376.02% | |
| 21 | Texas Capital Bank Wealth Management ServicesTexas Capital Bank Wealth Management Services | $312,789 | 0.74% | +9.92% | |
| 22 | Sequoia Financial AdvisorsSequoia Financial | $260,000 | 0.61% | new | |
| 23 | Gagnon SecuritiesGagnon Securities | $238,233 | 0.56% | −4.36% | |
| 24 | Stonepine Capital ManagementStonepine | $226,760 | 0.53% | new | |
| 25 | Palogic Value ManagementPalogic Value | $187,200 | 0.44% | 0.00% |
59 managers report $42.5M of Rein Therapeutics on form 13F for the quarter ended Jun 30 '26. 11 of them hold 80% of it; Voss Capital is largest at 12.88%.
Largest filed tie
—
Expected move
No implied move.